top
Search terms
Results 1 - 10 of 154 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 16
Eurointervention

Barwari A., Allawi N., Ahmed A. AIMS The current study is the first study from Iraq to address the different allelic variants of the gene CYP2C19, and to correlate them to the major cardiovascular ...

Date : 06/05/2016 Item size : 31434 bytes
Eurointervention

[...]we compared an amphilimus-eluting stent with 3 months of dual antiplatelet therapy to a zotarolimus-eluting stent in the complex setting of (troponin negative) diabetes. The major adverse ...

Date : 06/05/2016 Item size : 32362 bytes
Eurointervention

Patients were enrolled in a multicentre independent registry and divided in two groups: 1) patients discharged with Very Short Dual Antiplatelet Therapy (VS-DAPT; ≤3 months) because they were on ...

Date : 06/05/2016 Item size : 32048 bytes
Eurointervention

Fateh-moghadam S., Kümpel S., Schreieck J., Gawaz M., Bocksch W. AIMS The aim of this study was to investigate the safety and feasibility of LAA closure with the Amplatzer Cardiac Plug device in ...

Date : 06/05/2016 Item size : 32049 bytes
Eurointervention

Verdoia M., Barbieri L., Schaffer A., Marino P., Suryapranata H., De Luca G. AIMS The aim of the present study was to assess the role of gender on platelet function and the prevalence of high-on ...

Date : 06/05/2016 Item size : 31317 bytes
Eurointervention

EuroIntervention Impact of proton-pump inhibitors on clinical outcomes in patients treated with a six-month or 24-month DAPT duration: insights from the PRODIGY trial METHODS AND RESULTS We assessed ...

Date : 06/05/2016 Item size : 31498 bytes
Eurointervention

EuroIntervention Effect of aging on ischaemic and bleeding outcomes in patients undergoing a prolonged vs. shortened duration of DAPT: insights from the PRODIGY trial METHODS AND RESULTS The primary ...

Date : 06/05/2016 Item size : 31685 bytes
Eurointervention

Costa F., Adamo M., Ariotti S., Navarese E., Biondi-zoccai G., Valgimigli M. AIMS Despite evidence that extending DAPT with aspirin and thienopyridine beyond 12 months benefits ischaemic outcomes, ...

Date : 06/05/2016 Item size : 32711 bytes
Eurointervention

Michel J., Lohaus R., Mayer K., Lahmann A., Byrne R., Wolk A., Ten Berg J., Neumann F., Han Y., Adriaenssens T., Tölg R., Seyfarth M., Maeng M., Zrenner B., Jacobshagen C., Wöhrle J., Kufner S., ...

Date : 06/05/2016 Item size : 31544 bytes
Eurointervention

EuroIntervention Impact of chronic kidney disease on two-year clinical outcomes in patients treated with a six-month or 24-month DAPT duration: insights from the PRODIGY trial Santucci A., Gargiulo ...

Date : 06/05/2016 Item size : 31472 bytes